Blomqvist C, Wiklund T, Tarkkanen M, Elomaa I, Virolainen M
Department of Radiotherapy and Oncology, University of Helsinki, Finland.
Br J Cancer. 1993 Aug;68(2):414-7. doi: 10.1038/bjc.1993.351.
The volume doubling time (T2) of 52 lung metastases in 21 patients was calculated from measurements done on plain chest radiographs. Follow-up times ranged from 14 to 819 days. The measurements were fairly well reproducible in the majority of patients, although considerable discrepancies in T2 estimates made by two independent observers were found in a few patients. The median doubling time was 34.9 days (estimated 95% range 3.9 to 352 days). The variation of T2:s between patients was significantly (P = 0.0001) larger than that between T2: of multiple metastases in the same patients. The growth of the metastases seemed to be well described by a simple exponential function in all patients with more than two measurements, without evidence of Gompertzian growth. There seemed to be a linear correlation between the logarithm of T2 and log-survival time from diagnosis of metastatic disease, even if only one third of the variation of survival times between patients could be explained by differences in T2. T2 was not a significant factor for survival in Cox-analysis (P = 0.10).
通过对21例患者的52处肺转移灶进行胸部X线平片测量,计算出体积倍增时间(T2)。随访时间为14至819天。尽管在少数患者中发现两名独立观察者对T2的估计存在相当大的差异,但在大多数患者中,测量结果具有较好的可重复性。中位倍增时间为34.9天(估计95%范围为3.9至352天)。患者之间T2的差异显著(P = 0.0001),大于同一患者多处转移灶T2之间的差异。在所有进行了两次以上测量的患者中,转移灶的生长似乎可用简单指数函数很好地描述,没有证据表明存在Gompertzian生长。从转移性疾病诊断开始,T2的对数与对数生存时间之间似乎存在线性相关性,即使患者生存时间差异中只有三分之一可由T2差异解释。在Cox分析中,T2不是生存的显著因素(P = 0.10)。